Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults

NCT02333591 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Coronary Microvascular Dysfunction

Interventions

DRUG: GlucagonLikePeptide-1 (7-36)
DRUG: GlucagonLikePeptide-1 (9-36)
DRUG: Saline

Sponsor

Mette Zander

Collaborators

[object Object]